Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed against lymphocyte activation gene 3 (LAG-3)

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

US Patent 10836824 · Granted Nov 17, 2020

Estimated economic value: $5,237,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TNF-alpha variant fusion molecules2025
Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Anti-IL-18BP antibodies2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Claudin-6 antibodies and drug conjugates2024
Compositions and methods comprising anti-NRP2 antibodies2024